Highly predictive survival nomogram after upper urinary tract urothelial carcinoma

Cancer

Volumn 116, Issue 16, 2010, Pages 3774-3784

  Jeldres, Claudio ^a,b   Sun, Maxine ^a   Lughezzani, Giovanni ^a,c   Isbarn, Hendrik ^a,d   Shariat, Shahrokh F ^e   Widmer, Hugues ^a   Graefen, Markus ^d   Montorsi, Francesco ^c   Perrotte, Paul ^b   Karakiewicz, Pierre I ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Nephroureterectomy; Nomogram; Survival; Upper urinary tract urothelial carcinoma

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE SEVERITY; EXTERNAL VALIDITY; FEMALE; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; NOMOGRAM; PELVIS CANCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; URETER CANCER; URINARY TRACT CARCINOMA; UROTHELIUM; COMPARATIVE STUDY; KIDNEY NEOPLASMS; KIDNEY PELVIS; MIDDLE AGED; MORTALITY; NEPHRECTOMY; PATHOLOGY; TREATMENT OUTCOME; URETER; URETERAL NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; MIDDLE AGED; NEPHRECTOMY; NOMOGRAMS; PROGNOSIS; TREATMENT OUTCOME; URETER; URETERAL NEOPLASMS;

EID: 77956814163     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25122     Document Type: Article

References (46)

1. Oosterlinck W, Solsona E, van der Meijden AP, et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol. 2004;46:147-154. (Pubitemid 38902728)
2. Raman JD, Scherr DS. Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol. 2007;4:432-443. (Pubitemid 47244090)
3. Koukourakis G, Zacharias G, Koukourakis M, et al. Comprehensive management of upper tract urothelial carcinoma. Adv Urol. 2009;656521.
4. Taweemonkongsap T, Nualyong C, Amornvesukit T, et al. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy. World J Surg Oncol. 2008;6:3. (Pubitemid 351404652)
5. Yuasa T, Tsuchiya N, Narita S, et al. Radical nephroureterectomy as initial treatment for carcinoma in situ of upper urinary tract. Urology. 2006;68:972-975. (Pubitemid 44750134)
6. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998;52:594-601. (Pubitemid 28440164)
7. Novara G, De Marco V, Gottardo F, et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer. 2007;110:1715-1722. (Pubitemid 47557295)
8. Ozsahin M, Zouhair A, Villa S, et al. Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer. 1999;35:738-743. (Pubitemid 29258143)
9. Mullerad M, Russo P, Golijanin D, et al. Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol. 2004;172:2177-2181. (Pubitemid 39507486)
10. Brown GA, Matin SF, Busby JE, et al. Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology. 2007;70:252-256.
11. Kikuchi E, Margulis V, Karakiewicz PI, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 2009;27:612-618.
12. Oosterlinck W. Ureteral tumour: a specific upper urinary tract transitional cell carcinoma. Eur Urol. 2007;51:1164-1165. (Pubitemid 46436306)
13. Lee SH, Lin JS, Tzai TS, et al. Prognostic factors of primary transitional cell carcinoma of the upper urinary tract. Eur Urol. 1996;29:266-270, discussion 271.
14. Bolenz C, Shariat S, Fernandez MI, et al. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int. 2008;103:302-306.
15. Park S, Hong B, Kim CS, Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol. 2004;171:621-625. (Pubitemid 38090443)
16. Remzi M, Haitel A, Margulis V, et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int. 2009;103:307-311.
17. Ries LAG, Melbert D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute; 2007. http://seer.cancer.gov/csr/1975-2004/, based on November 2006 SEER data submission, posted to the SEER web site, 2007. Accessed January 2009.
18. Atkinson AC. A note on the generalized information criterion for choice of a model. Biometrika. 1980;67:413-418.
19. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
20. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
21. Stephenson AJ, Scardino PT, Eastham AJ, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst. 2006;98:715-717.
22. Hanley JA, Hajian-Tilaki KO. Sampling variability of nonparametic estimates of the areas under receiver operating characteristic curves: an update. Acad Radiol. 1997;4:49-58.
23. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under 2 or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845.
24. Huben RP, Mounzer AM, Murphy GP. Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer. 1988;62:2016-2020.
25. Kirkali Z, Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol. 2003;47:155-169. (Pubitemid 36945314)
26. Karakiewicz PI, Briganti A, Chun FK, et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol. 2007;25:1316-1322.
27. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res. 2006;12:6663-6676.
28. Zini L, Cloutier V, Isbarn H, et al. A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma. Clin Cancer Res. 2009;15:1013-1018.
29. Slovin SF, Wilton AS, Heller G, Scher HI. Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy. Clin Cancer Res. 2005;11:8669-8673. (Pubitemid 43005915)
30. Smaletz O, Scher HI, Small EJ, Verbel DA, McMillan A, Regan K, et al. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol. 2002;20:3972-3982.
31. Halabi S, Small EJ, Kantoff PW, et al. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol. 2003;21:1232-1237.
32. Wong SL, Kattan MW, McMasters KM, Coit DG. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer Staging System. Ann Surg Oncol. 2005;12:282-288.
33. Hiroyoshi S, Akira K, Naoto K, et al. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients. Urology. 2006;67:131-136.
34. O'Donnell P, Stadler W. The role of chemotherapy in upper tract urothelial carcinoma. Adv Urol. 2009;419028.
35. Latchamsetty KC, Porter CR. Treatment of upper tract urothelial carcinoma: a review of surgical and adjuvant therapy. Rev Urol. 2006;8:61-70.
36. Soga N, Arima K, Sugimura Y. Adjuvant methotrexate, vinblastine, Adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma. Int J Urol. 2008;15:800-803.
37. Kikuchi E, Margulis V, Karakiewicz P, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 2008;27:612-618.
38. Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224-1233.
39. Karakiewicz PI, Suardi N, Capitanio U, et al. A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. Eur Urol. 2008;55:287-295.
40. Margulis V, Lotan Y, Montorsi F, Shariat SF. Predicting survival after radical cystectomy for bladder cancer. BJU Int. 2008;102:15-22.
41. Karakiewicz PI, Shariat SF, Palapattu GS, et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol. 2006;176:1354-1361, discussion 61-62.
42. Consortium IBCN, Bochner BH, Kattan MW, Vora KC. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol. 2006;24:3967-3972.
43. Shariat S, Walz J, Roehrborn C, et al. External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy. J Clin Oncol. 2008;26:1526-1531.
44. Capitanio U, Shariat SF, Isbarn H, et al. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol. 2009;56:1-9.
45. Penson DF, Albertsen PC, Nelson CJ, Barry M, Stanford JL. Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst. 2001;93:1822-1823.
46. Hellenthal NJ, Shariat SF, Margulis V, et al. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from Upper Tract Urothelial Carcinoma Collaboration. J Urol. 2009;182:900-906.